Guardion Health Sciences, Inc. (GHSI) NASDAQ
$10.12 0.30 (3.06%)
Market Cap: $13M
As of 09/11/24 04:00 PM EDT. Market closed.
Guardion Health Sciences, Inc. (GHSI)
NASDAQ
$10.12
0.30 (3.06%)
Market Cap: $13M
As of 09/11/24 04:00 PM EDT. Market closed.
Add to Portfolio
Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Janet Hall
Full Time Employees
9
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Janet Hall
Full Time Employees
9
Address
15150 Avenue of Science, CA, San Diego, 92128.
PRICE CHART FOR GUARDION HEALTH SCIENCES, INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$9.77
Previous Close
$9.82
Days Range
$9.73 - $10.25
52 week range
$5.01 - $18
Volume
42,188
Avg. Volume (30 days)
84,170
Market Cap
$13M
Dividend Yield
49.41%
P/E
(2.46)
Shares Outstanding
1,284,160
Open
$9.77
Previous Close
$9.82
Days Range
$9.73 - $10.25
52 week range
$5.01 - $18
Volume
42,188
Avg. Volume (30 days)
84,170
Market Cap
$13M
Dividend Yield
49.41%
P/E
(2.46)
Shares Outstanding
1,284,160
FINANCIAL STATEMENTS FOR GUARDION HEALTH SCIENCES, INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR GUARDION HEALTH SCIENCES, INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Radoff Bradley Louis | 10% Owner | Aug 26, 2024 | Sale | $13.80 | 10,054 | 138,734 | 15,046 | Aug 28, 2024, 04:11 PM |
| Radoff Bradley Louis | 10% Owner | Aug 26, 2024 | Sale | $14.10 | 105,486 | 1,487,685 | 165,214 | Aug 28, 2024, 04:11 PM |
| Radoff Bradley Louis | 10% Owner | Jan 10, 2023 | Buy | $7.60 | 31,900 | 242,353 | 217,900 | Jan 11, 2023, 05:11 PM |
| Radoff Bradley Louis | 10% Owner | Jan 09, 2023 | Buy | $6.88 | 84,821 | 583,487 | 186,000 | Jan 11, 2023, 05:11 PM |
| Scholtes Bret | CEO and President | Jan 06, 2022 | Option Exercise | $0.65 | 37,175 | 24,164 | 294,980 | Jun 16, 2022, 04:10 PM |
| Scholtes Bret | CEO and President | Aug 31, 2021 | Buy | $1.23 | 5,500 | 6,760 | 179,484 | Sep 01, 2021, 04:20 PM |
| Scholtes Bret | CEO and President | Aug 30, 2021 | Buy | $1.26 | 4,500 | 5,656 | 173,984 | Sep 01, 2021, 04:20 PM |
| Gagliano Donald A | Director | Aug 30, 2021 | Buy | $1.25 | 5,000 | 6,250 | 27,750 | Aug 31, 2021, 04:20 PM |
| Gagliano Donald A | Director | Apr 09, 2019 | Option Exercise | $3.92 | 1,500 | 5,887 | 136,500 | Aug 31, 2021, 04:15 PM |
| WEINGARTEN ROBERT N | Director | Aug 20, 2021 | Option Exercise | $1.14 | 10,000 | 11,400 | 118,750 | Aug 23, 2021, 06:10 AM |
| Evans David W | Chief Science Officer | Oct 30, 2019 | Option Exercise | $0.33 | 2,000 | 664 | 1,544,500 | Oct 30, 2019, 03:00 PM |
| Evans David W | Chief Science Officer | Aug 15, 2019 | Option Exercise | $0.44 | 20,000 | 8,800 | 1,522,500 | Aug 22, 2019, 04:52 PM |
| Gagliano Donald A | Director | Apr 09, 2019 | Option Exercise | $3.92 | 1,500 | 5,887 | 136,250 | Apr 17, 2019, 04:40 PM |
| Goldstone Mark | Director | Apr 08, 2019 | Option Exercise | $3.53 | 300 | 1,060 | 525,300 | Apr 10, 2019, 04:14 PM |
| Evans David W | Chief Scientific Officer | Apr 09, 2019 | Option Exercise | $4.00 | 6,500 | 26,000 | 1,502,500 | Apr 10, 2019, 04:11 PM |
| WEINGARTEN ROBERT N | Director | Apr 09, 2019 | Option Exercise | $4.00 | 2,500 | 10,000 | 652,500 | Apr 10, 2019, 04:08 PM |
| FAVISH MICHAEL | Chief Executive Officer | Apr 09, 2019 | Option Exercise | $4.00 | 1,000 | 4,000 | 1,000 | Apr 10, 2019, 04:05 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Radoff Bradley Louis | 10% Owner | 08/26/2024 | 138,734 |
| Radoff Bradley Louis | 10% Owner | 08/26/2024 | 1,487,685 |
| Radoff Bradley Louis | 10% Owner | 01/10/2023 | 242,353 |
| Radoff Bradley Louis | 10% Owner | 01/09/2023 | 583,487 |
| Scholtes Bret | CEO and President | 01/06/2022 | 24,164 |
| Scholtes Bret | CEO and President | 08/31/2021 | 6,760 |
| Scholtes Bret | CEO and President | 08/30/2021 | 5,656 |
| Gagliano Donald A | Director | 08/30/2021 | 6,250 |
| Gagliano Donald A | Director | 04/09/2019 | 5,887 |
| WEINGARTEN ROBERT N | Director | 08/20/2021 | 11,400 |
| Evans David W | Chief Science Officer | 10/30/2019 | 664 |
| Evans David W | Chief Science Officer | 08/15/2019 | 8,800 |
| Gagliano Donald A | Director | 04/09/2019 | 5,887 |
| Goldstone Mark | Director | 04/08/2019 | 1,060 |
| Evans David W | Chief Scientific Officer | 04/09/2019 | 26,000 |
| WEINGARTEN ROBERT N | Director | 04/09/2019 | 10,000 |
| FAVISH MICHAEL | Chief Executive Officer | 04/09/2019 | 4,000 |
Load More Insider Transactions
FUNDS WITH A POSITION IN GUARDION HEALTH SCIENCES, INC.
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | 36,920 | 0.00063% | -2.38% | Other |
| BLACKROCK INC. | 10,030 | 0% | No change | Other |
CHANGE IN SHARES OUTSTANDING FOR GUARDION HEALTH SCIENCES, INC.
STOCK BUYBACKS FOR GUARDION HEALTH SCIENCES, INC.
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 03/31/2024
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
12/31/2023
1.32%
1Q
09/30/2023
0.54%
2Q
06/30/2023
1.02%
3Q
03/31/2023
1.02%
4Q
12/31/2022
3.90%
5Q
09/30/2022
3.92%
6Q
06/30/2022
4.00%
7Q
03/31/2022
63.51%
8Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR GUARDION HEALTH SCIENCES, INC.
LOADING...